Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 32 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

38%

12 trials in Phase 3/4

Results Transparency

9%

2 of 22 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

28Total
Not Applicable (10)
P 1 (3)
P 2 (3)
P 3 (3)
P 4 (9)

Trial Status

Completed22
Unknown6
Recruiting2
Active Not Recruiting1
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 22 completed trials

Clinical Trials (32)

Showing 20 of 20 trials
NCT07507591CompletedPrimary

Safety, Efficacy, and Short-Term Outcomes of Rezūm Water Vapor Thermal Therapy for Benign Prostatic Hyperplasia Under Local Anesthesia With Intravenous Sedation: A Single-Center Retrospective Study of 129 Patients in the Kurdistan Region of Iraq

NCT07283484Not ApplicableRecruiting

Early Versus Delayed Trial Without Catheter in Men With Acute Urinary Retention.

NCT07071207Not ApplicableRecruiting

Effect of Text Message Reminders on M-ISI Score After Prostate Surgery

NCT07014969Not ApplicableActive Not RecruitingPrimary

En-bloc With Early Apical Release Versus Lobe-by-lobe LASER Enucleation of the Prostate

NCT01747577Phase 4Completed

Post Marketing Study to Evaluate the Efficacy and Safety of Solifenacin in Patients With OAB (Overactive Bladder) After TURP (Trans-urethral Resection of Prostate) or PVP (Photoselective Vaporization of Prostate)

NCT02038868Phase 2CompletedPrimary

A Study to Evaluate the Efficacy and Safety of ASP4901 in Patients With Benign Prostate Hyperplasia

NCT02822924Not ApplicableCompletedPrimary

Prostate Artery Embolization for Symptomatic Benign Prostatic Hyperplasia

NCT02506465Not ApplicableCompletedPrimary

Pivotal Study to Assess the Safety and Effectiveness of the iTind Device

NCT02352311Phase 1CompletedPrimary

Safety and Pharmacokinetic Characteristics of DKF-313

NCT02332538Not ApplicableCompletedPrimary

HoLEP vs. Greenlight 532nm-laser PVEP vs. Bipolar TURP in Management of Moderate/ Large BPH

NCT03831321Phase 4Unknown

The Effect of Preemptive Analgesia On The Comfort Of Patient and Doctor, in Cystoscopy

NCT03776006Not Yet Recruiting

Registry: TPLA for LUTS

NCT01436877Not ApplicableCompleted

Assessing Safety & Efficacy of MediTate Temporary Implant in Subjects With Benign Prostate Hyperplasia

NCT02873117CompletedPrimary

Evaluation of the Potential Association Between 5α-reductase Inhibitors Prescription and Occurrence of High Grade Prostate Cancers

NCT01937871Phase 3CompletedPrimary

A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED)

NCT02423759Phase 4CompletedPrimary

A Trial Assessing Peri-procedure Chemoprophylaxis During Transrectal Prostate Needle Biopsy

NCT02839122Phase 1CompletedPrimary

A Study to Investigate the Pharmacokinetic Drug Interactions Between Dutasteride and Tadalafil in Healthy Male Subjects

NCT02483819CompletedPrimary

Changes of the Hemodynamic Profiles on Bio Reactance Technique During TURP in Elderly Patients

NCT02390882Phase 3CompletedPrimary

A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPH

NCT02827578Phase 3UnknownPrimary

Efficacy and Safety of Tamsulosin/Solifenacin Combination Therapy in Patients With Voiding Symptoms and Moderate to Severe Storage Symptoms Due to Benign Prostate Hyperplasia

Scroll to load more

Research Network

Activity Timeline